Inspection readiness depends as much on governance as it does on technology. This article looks at the models sponsors use to maintain review discipline, accountability, and control over trial documentation.
A document can be present in the TMF and still be late, inaccurate, misclassified, or unusable. Understanding the difference between completeness and quality is essential to meaningful inspection readiness.
Buying an eTMF does not automatically create an inspection-ready process. True readiness depends on governance, structure, ownership, review practices, and how the system is used day to day.
Enlighten Clinical Solutions has completed SOC 2 Type II, HIPAA, and GDPR audits, marking an important milestone in the company’s commitment to security, privacy, and regulatory alignment for life sciences organizations.
EDC gives sponsors visibility into trial data, but access alone is not oversight. This practical overview looks at governance, monitoring, and the responsibilities sponsors retain in EDC-enabled studies.
Audit readiness is more than having a validated EDC system. Sponsors also need clear oversight, reliable audit trails, documented processes, and confidence that the system reflects how the study is actually being managed.
EDC audit preparation does not have to become a last-minute exercise. This guide focuses on the practical controls, documentation, audit trails, and sponsor responsibilities that support ongoing inspection readiness.
An EDC system that works for one study should not become a bottleneck as programs grow. Learn what to consider as site counts, users, data volume, and study portfolios expand.
Effective data monitoring is not about reviewing everything with equal urgency. Strong EDC workflows help teams prioritize the right signals, manage queries efficiently, and focus attention where it matters most.
Many EDC problems begin before the first subject is enrolled. This article looks at common implementation risks, from planning and configuration gaps to training, adoption, and governance.
